NCT01675128View on ClinicalTrials.gov

ISIS 183750 With Irinotecan for Advanced Solid Tumors or Colorectal Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2015

Conditions
Colorectal NeoplasmsColorectal CarcinomaColorectal Tumors
Interventions
DRUG

ISIS 183750

DRUG

Irinotecan

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT01675128 - ISIS 183750 With Irinotecan for Advanced Solid Tumors or Colorectal Cancer | Biotech Hunter | Biotech Hunter